Reaction

Vulvovaginal Burning Sensation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 6,016 reports · 41 co-occurring drugs

As of the last recalculation, Vulvovaginal Burning Sensation appears in 6,016 FAERS reports alongside 41 co-occurring drug terms. The strongest observed disproportionality signal is MICONAZOLE NITRATE (PRR 1,070.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Miconazole Nitrate	1,864	1,070.2	1,362.7
Conjugated Estrogens	441	28.2	28.4
Estrogens, Conjugated	441	27.7	27.9
Estradiol	585	25.8	26.0
Estradiol Gel 0.1%	203	16.0	16.1
Estradiol Transdermal	203	16.0	16.1
Etonogestrel And Ethinyl Estradiol	71	11.2	11.2
Drs. Clotrimazole	30	9.0	9.0
Family Wellness Clotrimazole	30	9.0	9.0
Clotrimazole Topical	30	9.0	9.0
Clotrimazole	31	8.8	8.8
Dicyclomine Hydrochloride	26	6.3	6.3
Clindamycin Phosphate	42	4.4	4.4
Clobetasol Propionate Ointment Usp, 0.05%	12	4.0	4.0
Clobetasol Propionate	12	4.0	4.0
Anastrozole Tablets	23	3.7	3.7
Thyroid, Porcine	11	3.6	3.6
Biotin	32	3.6	3.6
Anastrozole	37	3.5	3.5
Progesterone	23	3.5	3.5
Vibegron	8	3.5	3.5
Salmeterol Xinafoate	8	3.2	3.2
Copper	39	3.1	3.1
Fluconazole	59	2.9	2.9
Ciprofolxacin	60	2.9	2.9
Ciprofloxacin Tablets	60	2.9	2.9
Irbesartan	37	2.9	2.9
Ciprofloxacin Hydrochloride	80	2.9	2.9
Empagliflozin	55	2.8	2.8
Fenofibrate	29	2.8	2.8
Ciprofloxacin	74	2.8	2.8
Oxybutynin Chloride	7	2.8	2.8
Ciprofloxacin Hydrochloride And Hydrocortisone	16	2.7	2.7
Canagliflozin	19	2.2	2.2
Iron Sucrose	6	2.2	2.2
Levonorgestrel	118	2.0	2.0
Mirabegron	18	1.6	1.6
Conjugated Estrogens And Medroxyprogesterone Acetate	7	1.0	1.0
Peginterferon Alfa-2A	16	1.0	1.0
Etonogestrel	10	0.7	0.7
Dulaglutide	17	0.7	0.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.